Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice
Mesenchymal stem cell (MSC)-based therapy is a promising therapeutic approach in the management of several pathologies, including central nervous system diseases. Previously, we demonstrated the therapeutic potential of human adipose-derived MSCs for neurological sequelae of oncological radiotherapy...
Main Authors: | Yolanda Aguilera, Nuria Mellado-Damas, Laura Olmedo-Moreno, Víctor López, Concepción Panadero-Morón, Marina Benito, Hugo Guerrero-Cázares, Catalina Márquez-Vega, Alejandro Martín-Montalvo, Vivian Capilla-González |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/5/1169 |
Similar Items
-
Human Mesenchymal Stem Cells Prevent Neurological Complications of Radiotherapy
by: Bernat Soria, et al.
Published: (2019-05-01) -
Preoperative intranasal dexmedetomidine versus intranasal ketamine for prevention of emergence agitation after sevoflurane in myringotomy patients: A randomized clinical trial
by: Hoda Alsaid Ahmed Ezz
Published: (2017-04-01) -
Comparative study between intranasal dexmedetomidine and intranasal ketamine as a premedication for anxiolysis and sedation before pediatric general anesthesia
by: Ahmed Elsayed Ahmed Mohamed Elshafeey, et al.
Published: (2020-10-01) -
Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye
by: Ye Tao, et al.
Published: (2019-01-01) -
Advances in intranasal application of stem cells in the treatment of central nervous system diseases
by: Yu-Ting Zhang, et al.
Published: (2021-03-01)